SIRT6 and breast carcinoma: Also, Andreani et al. demonstrated that SIRT6 overexpression promotes migration, invasion, and lung metastasis in the Delta16HER2 mice model of breast cancer [218], thus suggesting SIRT6 as a cell progression factor in breast cancer.